ArticleContemporary clinical trials communications2026
Protocol for a prospective, single-arm pilot trial assessing the clinical and supraspinal neural effects of non-invasive transcranial neuromodulation in adults with overactive bladder.
Article in Contemporary clinical trials communications, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT06198439 (Higher Neural and Clinical Effects of Non-Invasive Transcranial Neuromodulation in Adults With Overactive Bladder), which is not on this map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Higher Neural and Clinical Effects of Non-Invasive Transcranial Neuromodulation in Adults With Overactive Bladder
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: Overactive bladder (OAB) is a prevalent condition characterized by urinary urgency, frequency, and nocturia, with or without urge urinary incontinence. It significantly affects quality of life and is associated with increased rates of depression and sexual dysfunction. Lower urinary tract (LUT) control relies on coordinated activity across peripheral, spinal, and supraspinal networks. Individuals with OAB exhibit abnormal supraspinal network activity. Current treatments primarily target peripheral pathways and have limited efficacy. Repetitive transcranial magnetic stimulation (rTMS) offers a non-invasive approach to modulate networks involved in LUT control. Methods: This prospective, single-center, single-arm, pilot trial evaluates the clinical and neural effects of neuronavigated rTMS in individuals with OAB. Baseline functional MRI (fMRI) guides individualized targeting of OAB-relevant regions. Participants undergo five sessions of low-frequency stimulation of the pelvic supplementary motor area (SMA) followed by high-frequency rTMS to the dorsolateral prefrontal cortex (DLPFC). Primary endpoints are changes in LUT control network functional connectivity (FC) during full and empty bladder conditions. Secondary outcomes include changes in OAB symptoms, urinary frequency and incontinence episodes, quality of life, and patient-perceived bladder condition. Pelvic floor muscle (PFM) electromyography (EMG) recorded during the first and fifth sessions provides exploratory physiological outcomes. Clinical outcomes are assessed immediately, three and six weeks post-treatment. Discussion: This study is the first to evaluate non-invasive neuromodulation of supraspinal regions in individuals with OAB. By targeting brain networks involved in LUT control, this neuronavigated approach may improve FC and provide a novel therapeutic strategy for individuals with OAB refractory to conventional treatments. Trial registration number: NCT06198439. Participant enrollment and follow-up have been completed.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.